{
    "SPADE_UN_18856": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18856",
            "Peptide Name": "R14 (Synthetic AMPs, Lys-rich, UCLL1)",
            "Source": "amphipahtic designed",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "KKIAKKFWKKFWKFWPKFWKIFKK",
            "Sequence Length": 24,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 3303.13,
            "PI": 11.0,
            "Hydrophobicity": -0.97,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Ramata-Stunda A, Boroduskis M, Kaktina E, Patetko L, Kalnenieks U, Lasa Z, Rubina M, Strazdina I, Kalnins G, Rutkis R. 2023",
                    "Reference": "Antibiotics (Basel). 2023 Mar 10;12(3):551. doi: 10.3390/antibiotics12030551.PubMed",
                    "Title": "Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections"
                }
            ],
            "Frequent Amino Acids": "KFW",
            "Absent Amino Acids": "CDEGHLMNOQRSTUVY",
            "Basic Residues": 11,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 13,
            "Polar Residues": 12,
            "Positive Residues": 11,
            "Negative Residues": 0,
            "Net Charge": 11,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (52%) toPexigananK: 46%; F: 21%; W: 17%.Activity: Active against E. coli (MIC 16.0 ug/ml), P. aeruginosa (MIC 4.0 ug/ml), K. pneumonia (MIC 4.0 ug/ml), E. faecium (MIC 8.0 ug/ml), S. aureus (MIC 8.0 ug/ml), and C. acnes (MIC 1.0 ug/ml).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11295",
                    "Similarity": 1.0,
                    "Sequence": "KIFKKIEKVGRNVRDGIIKAGPAVAVVEQA"
                },
                {
                    "SPADE_ID": "SPADE_UN_18852",
                    "Similarity": 1.0,
                    "Sequence": "KKIAKKFWKKFWKFWKIFKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_18854",
                    "Similarity": 1.0,
                    "Sequence": "IAKKFWKKFWKFWKIFKKIA"
                }
            ]
        }
    }
}